92 related articles for article (PubMed ID: 34838343)
1. A real-world, population-based study of the trends for incidence and prognosis in high-grade neuroendocrine tumor of cervix.
Yang XL; Guan WJ; Kou LN; Wang MM; Lai H; Wu DJ
Curr Probl Cancer; 2022 Apr; 46(2):100800. PubMed ID: 34838343
[TBL] [Abstract][Full Text] [Related]
2. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
3. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
[TBL] [Abstract][Full Text] [Related]
4. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
Cai JS; Chen HY; Lu YF; Yu RS
Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
[No Abstract] [Full Text] [Related]
5. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
8. Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.
Yang Z; Wang W; Lu J; Pan G; Pan Z; Chen Q; Liu W; Zhao Y
Cell Physiol Biochem; 2018; 45(1):389-396. PubMed ID: 29402806
[TBL] [Abstract][Full Text] [Related]
9. Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors.
Lu G; Li J; Wu L; Shi Y; Zhang X; Xia Y; Li L
Dig Dis; 2022; 40(1):50-61. PubMed ID: 33752202
[TBL] [Abstract][Full Text] [Related]
10. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract][Full Text] [Related]
11. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
12. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram prognostic model for patients with neuroendocrine tumors of the thymus.
Tang JY; Gao HJ; Shi GD; Guo XK; Yu WQ; Wang HF; Wei YC
Thorac Cancer; 2020 Sep; 11(9):2457-2464. PubMed ID: 32656987
[TBL] [Abstract][Full Text] [Related]
14. Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
Xie G; Wang R; Shang L; Qi C; Yang L; Huang L; Yang W; Chung MC
BMC Cancer; 2020 Sep; 20(1):833. PubMed ID: 32873257
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for individually predicting overall survival in rectal neuroendocrine tumours.
Feng X; Wei G; Wang W; Zhang Y; Zeng Y; Chen M; Chen Y; Chen J; Zhou Z; Li Y
BMC Cancer; 2020 Sep; 20(1):865. PubMed ID: 32907602
[TBL] [Abstract][Full Text] [Related]
17. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
[TBL] [Abstract][Full Text] [Related]
18. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms.
Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q
World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382
[TBL] [Abstract][Full Text] [Related]
20. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
